28 results
Thumbnail

D2.19 - Can Drug Provocation Be Avoided in Low-Risk Quinolone Reactions?

Thumbnail

D2.25 - Epicutaneous responses to Bradykinin Receptor 1 and 2 agonists, Histamine, and mast cell agonists in Angiotensin Converting Enzyme Inhibitor angioedema

Thumbnail

D2.17 - Diagnostic profitability of penicilloyl-polylysine and minor determinant mixture in urgent/preferred beta-lactam allergy studies in hospitalized patients from january 2023 to december 2025

Thumbnail

D2.18 - Evaluating the Penicillin Allergy Diagnosis Process with Real-Life Data

Thumbnail

D2.20 - Selective Fixed Drug Eruption from Etoricoxib with Safe Celecoxib Use: Role of Patch Testing

Thumbnail

D2.21 - The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity

Thumbnail

D2.26 - Applying a phenotype-driven diagnostic algorithm to suspected hypersensitivity reactions to biologicals: a real-world experience

Thumbnail

D2.27 - “Chronic Urticaria Following Dental Filling Procedure: A Clinical Evaluation”

Thumbnail

D2.28 - When Cross-Reactivity Is Not the Answer: Immediate Multiple Drug Hypersensitivity to Aminopenicillins and Ceftriaxone

Thumbnail

D2.29 - Use and knowledge of Phadiatop Infant and Fx5 in children from a primary care healthcare area

Thumbnail

D3.430 - The effect of biological treatment of atopic dermatitis in children

Thumbnail

D3.431 - Dupilumab therapy of patients with chronic rhinosinusitis with nasal polyps: long-term observational study

Thumbnail

D3.432 - Severe chronic rhinosinusitis - diagnostic and therapeutic challenges, personalized approach and place of biological treatment: a clinical case

Thumbnail

D3.433 - An effect on lipid profile of biologic therapy independent from weight variation

Thumbnail

D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data

Thumbnail

D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial